FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Gianni Bonadonna

Research Profile

Procedures

Disorders

Chemicals & Drugs

Concepts & Ideas

Co-author Network

Publications

TOP 3
Romano Demicheli; Elia Biganzoli; Ilaria Ardoino; Patrizia Boracchi; Danila Coradini; Marco Greco; Angela Moliterni; Milvia Zambetti; Pinuccia Valagussa; Isaac D Gukas; Gianni Bonadonna
Recurrence and mortality dynamics for breast cancer patients undergoing mastectomy according to estrogen receptor status: different mortality but similar recurrence.
Luca Gianni; Larry Norton; Norman Wolmark; Thomas M Suter; Gianni Bonadonna; Gabriel N Hortobagyi
Role of anthracyclines in the treatment of early breast cancer.
Luca Gianni; José Baselga; Wolfgang Eiermann; Vincente Guillem Porta; Vladimir Semiglazov; Ana Lluch; Milvia Zambetti; Dolores Sabadell; Günther Raab; Antonio Llombart Cussac; Alla Bozhok; Angel Martinez-Agulló; Marco Greco; Mikhail Byakhov; Juan Josè Lopez Lopez; Mauro Mansutti; Pinuccia Valagussa; Gianni Bonadonna
Phase III trial evaluating the addition of paclitaxel to doxorubicin followed by cyclophosphamide, methotrexate, and fluorouracil, as adjuvant or primary systemic therapy: European Cooperative Trial in Operable Breast Cancer.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Gianni Bonadonna (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2010: Romano Demicheli; Elia Biganzoli; Ilaria Ardoino; Patrizia Boracchi; Danila Coradini; Marco Greco; Angela Moliterni; Milvia Zambetti; Pinuccia Valagussa; Isaac D Gukas; Gianni Bonadonna
Recurrence and mortality dynamics for breast cancer patients undergoing mastectomy according to estrogen receptor status: different mortality but similar recurrence.
Cancer science 2010;101(3):826-30.
2009: Luca Gianni; Larry Norton; Norman Wolmark; Thomas M Suter; Gianni Bonadonna; Gabriel N Hortobagyi
Role of anthracyclines in the treatment of early breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(28):4798-808.
2009: Luca Gianni; José Baselga; Wolfgang Eiermann; Vincente Guillem Porta; Vladimir Semiglazov; Ana Lluch; Milvia Zambetti; Dolores Sabadell; Günther Raab; Antonio Llombart Cussac; Alla Bozhok; Angel Martinez-Agulló; Marco Greco; Mikhail Byakhov; Juan Josè Lopez Lopez; Mauro Mansutti; Pinuccia Valagussa; Gianni Bonadonna
Phase III trial evaluating the addition of paclitaxel to doxorubicin followed by cyclophosphamide, methotrexate, and fluorouracil, as adjuvant or primary systemic therapy: European Cooperative Trial in Operable Breast Cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(15):2474-81.
2007: Romano Demicheli; William J M Hrushesky; Michael Retsky; Gianni Bonadonna; Pinuccia Valagussa
Comment to "Effect of primary tumor extirpation in breast cancer patients who present with stage IV disease and intact primary tumor" by G V Babiera, R Rao, L Feng, F Meric-Bernstam, H M Kuerer, S E Singletary, K K Hunt, M I Ross, K M Gwyn, B W Feig, F C Ames, G N Horthobagyi. Ann Surg Oncol 2006;13:776-782.
Annals of surgical oncology 2007;14(4):1519-20.
2006: Romano Demicheli; Gianni Bonadonna; Marco Greco; William J M Hrushesky; Angela Moliterni; Michael Retsky; Pinuccia Valagussa; Milvia Zambetti
Comment to Anderson WF, Jatoi I, Devesa SS: distinct breast cancer incidence and prognostic patterns in the NCI'S SEER program: suggesting a possible link between etiology and outcome. Breast Cancer Res Treat 90:127-137, 2005.
Breast cancer research and treatment 2006;97(3):341-3.
2005: Luca Gianni; José Baselga; Wolfgang Eiermann; Vicente Guillem Porta; Vladimir Semiglazov; Ana Lluch; Milvia Zambetti; Dolores Sabadell; Günther Raab; Antonio Llombart-Cussac; Alla Bozhok; Angel Martinez-Agulló; Marco Greco; Mikhail Byakhov; Juan Josè Lopez Lopez; Mauro Mansutti; Pinuccia Valagussa; Gianni Bonadonna
Feasibility and tolerability of sequential doxorubicin/paclitaxel followed by cyclophosphamide, methotrexate, and fluorouracil and its effects on tumor response as preoperative therapy.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(24 Pt 1):8715-21.
2005: Romano Demicheli; Gianni Bonadonna; Pinuccia Valagussa; Michael Retsky; William J M Hrushesky; Michael Baum
Comment to Jatoi et al. report.
Breast cancer research and treatment 2005;93(1):1-2.
2005: Romano Demicheli; Rosalba Miceli; Angela Moliterni; Milvia Zambetti; William J M Hrushesky; Michael Retsky; Pinuccia Valagussa; Gianni Bonadonna
Breast cancer recurrence dynamics following adjuvant CMF is consistent with tumor dormancy and mastectomy-driven acceleration of the metastatic process.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2005;16(9):1449-57.
2005: Gianni Bonadonna; Simonetta Viviani; Valeria Bonfante; ALESSANDRO MASSIMO GIANNI; Pinuccia Valagussa
Survival in Hodgkin's disease patients--report of 25 years of experience at the Milan Cancer Institute.
European journal of cancer (Oxford, England : 1990) 2005;41(7):998-1006.
2005: Gianni Bonadonna; Angela Moliterni; Milvia Zambetti; Maria Grazia Daidone; Silvana Pilotti; Luca Gianni; Pinuccia Valagussa
30 years' follow up of randomised studies of adjuvant CMF in operable breast cancer: cohort study.
BMJ (Clinical research ed.) 2005;330(7485):217.
2004: Carlo Visco; Theodoros P Vassilakopoulos; Kay-Oliver Kliche; Gianpaolo Nadali; Simonetta Viviani; Valeria Bonfante; L Jeffrey Medeiros; P Notti; George Z Rassidakis; Prema P Peethambaram; Richard Wilder; Thomas E Witzig; ALESSANDRO MASSIMO GIANNI; Gianni Bonadonna; Giovanni Pizzolo; Gerassimos A Pangalis; Fernando Cabanillas; Andreas H Sarris
Elevated serum levels of IL-10 are associated with inferior progression-free survival in patients with Hodgkin's disease treated with radiotherapy.
Leukemia & lymphoma 2004;45(10):2085-92.
2004: Gianni Bonadonna; Valeria Bonfante; Simonetta Viviani; Anna Di Russo; Fabrizio Villani; Pinuccia Valagussa
ABVD plus subtotal nodal versus involved-field radiotherapy in early-stage Hodgkin's disease: long-term results.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(14):2835-41.
2004: Gianni Bonadonna; Milvia Zambetti; Angela Moliterni; Luca Gianni; Pinuccia Valagussa
Clinical relevance of different sequencing of doxorubicin and cyclophosphamide, methotrexate, and Fluorouracil in operable breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(9):1614-20.
2004: Romano Demicheli; Gianni Bonadonna; William J M Hrushesky; Michael Retsky; Pinuccia Valagussa
Menopausal status dependence of the timing of breast cancer recurrence after surgical removal of the primary tumour.
Breast cancer research : BCR 2004;6(6):R689-96.
2004: Michael Retsky; Gianni Bonadonna; Romano Demicheli; Judah Folkman; William J M Hrushesky; Pinuccia Valagussa
Hypothesis: Induced angiogenesis after surgery in premenopausal node-positive breast cancer patients is a major underlying reason why adjuvant chemotherapy works particularly well for those patients.
Breast cancer research : BCR 2004;6(4):R372-4.
2004: Romano Demicheli; Gianni Bonadonna; William J M Hrushesky; Michael Retsky; Pinuccia Valagussa
Menopausal status dependence of early mortality reduction due to diagnosis of smaller breast cancers (T1 v T2-T3): relevance to screening.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(1):102-7.
2003: Marco Herling; George Z Rassidakis; L Jeffrey Medeiros; Theodoros P Vassilakopoulos; Kay-Oliver Kliche; Gianpaolo Nadali; Simonetta Viviani; Valeria Bonfante; Roberto Giardini; Marco Chilosi; Christos Kittas; ALESSANDRO MASSIMO GIANNI; Gianni Bonadonna; Giovanni Pizzolo; Gerassimos A Pangalis; Fernando Cabanillas; Andreas H Sarris
Expression of Epstein-Barr virus latent membrane protein-1 in Hodgkin and Reed-Sternberg cells of classical Hodgkin's lymphoma: associations with presenting features, serum interleukin 10 levels, and clinical outcome.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(6):2114-20.
2003: Lisa Licitra; Laura D Locati; Raffaele Cavina; Isabella Garassino; Franco Mattavelli; Natalia Pizzi; Pasquale Quattrone; Pinuccia Valagussa; Luca Gianni; Gianni Bonadonna; Carlo L Solero; Giulio Cantu
Primary chemotherapy followed by anterior craniofacial resection and radiotherapy for paranasal cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2003;14(3):367-72.
2003: Angela Moliterni; Sylvie Ménard; Pinuccia Valagussa; Elia Biganzoli; Patrizia Boracchi; Andrea Balsari; Patrizia Casalini; Gorana Tomasic; Ettore Marubini; Silvana Pilotti; Gianni Bonadonna
HER2 overexpression and doxorubicin in adjuvant chemotherapy for resectable breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(3):458-62.
2003: Lisa Licitra; Cesare Grandi; Marco Guzzo; Luigi Mariani; Salvatore Lo Vullo; Francesca Valvo; Pasquale Quattrone; Pinuccia Valagussa; Gianni Bonadonna; Roberto Molinari; Giulio Cantù
Primary chemotherapy in resectable oral cavity squamous cell cancer: a randomized controlled trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(2):327-33.
2003: Pinuccia Valagussa; Gianni Bonadonna
Breast cancer.
Cancer chemotherapy and biological response modifiers 2003;21():585-608.
2002: George Z Rassidakis; L Jeffrey Medeiros; Theodoros P Vassilakopoulos; Simonetta Viviani; Valeria Bonfante; Gianpaolo Nadali; Marco Herling; Maria K Angelopoulou; Roberto Giardini; Marco Chilosi; Christos Kittas; Timothy J McDonnell; Gianni Bonadonna; ALESSANDRO MASSIMO GIANNI; Giovanni Pizzolo; Gerassimos A Pangalis; Fernando Cabanillas; Andreas H Sarris
BCL-2 expression in Hodgkin and Reed-Sternberg cells of classical Hodgkin disease predicts a poorer prognosis in patients treated with ABVD or equivalent regimens.
Blood 2002;100(12):3935-41.
2002: Romano Demicheli; Pinuccia Valagussa; Gianni Bonadonna
Double-peaked time distribution of mortality for breast cancer patients undergoing mastectomy.
Breast cancer research and treatment 2002;75(2):127-34.
2002: Gianni Bonadonna; Milvia Zambetti; Cesare Bumma; Michela Donadio; A Bolognesi; Gioacchino Robustelli Della Cuna; G Ambrosini; Giorgio Lelli; Mauro Mansutti; P Verderio; Pinuccia Valagussa
Multimodal treatment with primary single-agent epirubicin in operable breast cancer: 5-year experience of the Michelangelo Cooperative Group.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2002;13(7):1049-58.
2002: George Z Rassidakis; L Jeffrey Medeiros; Simonetta Viviani; Valeria Bonfante; Gianpaolo Nadali; Theodoros P Vassilakopoulos; Ofelia M Mesina; Marco Herling; Maria K Angelopoulou; Roberto Giardini; Marco Chilosi; Christos Kittas; Peter McLaughlin; Maria A Rodriguez; Jorge Romaguera; Gianni Bonadonna; ALESSANDRO MASSIMO GIANNI; Giovanni Pizzolo; Gerassimos A Pangalis; Fernando Cabanillas; Andreas H Sarris
CD20 expression in Hodgkin and Reed-Sternberg cells of classical Hodgkin's disease: associations with presenting features and clinical outcome.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(5):1278-87.
2002: George Z Rassidakis; L Jeffrey Medeiros; Timothy J McDonnell; Simonetta Viviani; Valeria Bonfante; Gianpaolo Nadali; Theodoros P Vassilakopoulos; Roberto Giardini; Marco Chilosi; Christos Kittas; ALESSANDRO MASSIMO GIANNI; Gianni Bonadonna; Giovanni Pizzolo; Gerassimos A Pangalis; Fernando Cabanillas; Andreas H Sarris
BAX expression in Hodgkin and Reed-Sternberg cells of Hodgkin's disease: correlation with clinical outcome.
Clinical cancer research : an official journal of the American Association for Cancer Research 2002;8(2):488-93.
2002: Paolo Bidoli; Emilio Bajetta; Simonetta Chiara Stani; Candis Daniela De; Armando Santoro; Maurizio Valente; Roberto Zucali; Pinuccia Valagussa; Gianni Ravasi; Gianni Bonadonna
Ten-year survival with chemotherapy and radiotherapy in patients with squamous cell carcinoma of the esophagus.
Cancer 2002;94(2):352-61.
2001: G Mariani; P Tagliabue; P Zucchinelli; C Brambilla; Romano Demicheli; E Villa; A Marchianò; Pinuccia Valagussa; Gianni Bonadonna; Luca Gianni
Phase I/II study of gemcitabine in association with vinorelbine for metastatic breast cancer.
Breast cancer research and treatment 2001;70(3):163-9.
2001: Romano Demicheli; Pinuccia Valagussa; Gianni Bonadonna
Does surgery modify growth kinetics of breast cancer micrometastases?
British journal of cancer 2001;85(4):490-2.
2001: Valeria Bonfante; Simonetta Viviani; liliana devizzi; Anna Di Russo; Massimo Di Nicola; Michele Magni; Paola Matteucci; Salvatore Grisanti; Pinuccia Valagussa; Gianni Bonadonna; ALESSANDRO MASSIMO GIANNI
High-dose ifosfamide and vinorelbine as salvage therapy for relapsed or refractory Hodgkin's disease.
European journal of haematology. Supplementum 2001;64():51-5.
2001: Luca Gianni; Pinuccia Valagussa; Milvia Zambetti; Angela Moliterni; Giuseppe Capri; Gianni Bonadonna
Adjuvant and neoadjuvant treatment of breast cancer.
Seminars in oncology 2001;28(1):13-29.
2001: Sylvie Ménard; Pinuccia Valagussa; Silvana Pilotti; Luca Gianni; Elia Biganzoli; Patrizia Boracchi; Gorana Tomasic; Patrizia Casalini; Ettore Marubini; MI Colnaghi; Natale Cascinelli; Gianni Bonadonna
Response to cyclophosphamide, methotrexate, and fluorouracil in lymph node-positive breast cancer according to HER2 overexpression and other tumor biologic variables.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(2):329-35.
2001: Pinuccia Valagussa; Gianni Bonadonna
Breast cancer.
Cancer chemotherapy and biological response modifiers 2001;19():597-628.
2001: Milvia Zambetti; Angela Moliterni; C Materazzo; M Stefanelli; sonia cipriani; Pinuccia Valagussa; Gianni Bonadonna; Luca Gianni
Long-term cardiac sequelae in operable breast cancer patients given adjuvant chemotherapy with or without doxorubicin and breast irradiation.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(1):37-43.
2000: Michele Magni; Massimo Di Nicola; liliana devizzi; Paola Matteucci; F Lombardi; Lorenza Gandola; Fernando Ravagnani; Roberto Giardini; G Dastoli; Corrado Tarella; Alessandro Pileri; Gianni Bonadonna; ALESSANDRO MASSIMO GIANNI
Successful in vivo purging of CD34-containing peripheral blood harvests in mantle cell and indolent lymphoma: evidence for a role of both chemotherapy and rituximab infusion.
Blood 2000;96(3):864-9.
2000: R Silvestrini; A Luisi; Milvia Zambetti; sonia cipriani; Pinuccia Valagussa; Gianni Bonadonna; Maria Grazia Daidone
Cell proliferation and outcome following doxorubicin plus CMF regimens in node-positive breast cancer.
International journal of cancer. Journal international du cancer 2000;87(3):405-11.
2000: A Santoro; Henning Bredenfeld; liliana devizzi; Hans Tesch; Valeria Bonfante; Simonetta Viviani; F Fiedler; H S Parra; C Benoehr; M Pacini; Gianni Bonadonna; Volker Diehl
Gemcitabine in the treatment of refractory Hodgkin's disease: results of a multicenter phase II study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000;18(13):2615-9.
2000: C Tondini; Monica Balzarotti; I Rampinelli; Pinuccia Valagussa; M Luoni; Alberto De Paoli; Armando Santoro; Gianni Bonadonna
Fludarabine and cladribine in relapsed/refractory low-grade non-Hodgkin's lymphoma: a phase II randomized study.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2000;11(2):231-3.
2000: Simonetta Viviani; P Notti; Valeria Bonfante; P Verderio; Pinuccia Valagussa; Gianni Bonadonna
Elevated pretreatment serum levels of Il-10 are associated with a poor prognosis in Hodgkin's disease, the milan cancer institute experience.
Medical oncology (Northwood, London, England) 2000;17(1):59-63.
1999: C Tondini; A J Ferreri; L Siracusano; Pinuccia Valagussa; Roberto Giardini; I Rampinelli; Gianni Bonadonna
Diffuse large-cell lymphoma of the testis.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(9):2854-8.
1999: Simonetta Viviani; Valeria Bonfante; Armando Santoro; M Zanini; liliana devizzi; Anna Di Russo; F Soncini; Fabrizio Villani; G Ragni; Pinuccia Valagussa; Gianni Bonadonna
Long-term results of an intensive regimen: VEBEP plus involved-field radiotherapy in advanced Hodgkin's disease.
The cancer journal from Scientific American 1999;5(5):275-82.
1999: Milvia Zambetti; Saro Oriana; Pasquale Quattrone; P Verderio; Monica Terenziani; Roberto Zucali; Pinuccia Valagussa; Gianni Bonadonna
Combined sequential approach in locally advanced breast cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1999;10(3):305-10.
1999: Romano Demicheli; Rosalba Miceli; C Brambilla; L Ferrari; Angela Moliterni; Milvia Zambetti; Pinuccia Valagussa; Gianni Bonadonna
Comparative analysis of breast cancer recurrence risk for patients receiving or not receiving adjuvant cyclophosphamide, methotrexate, fluorouracil (CMF). Data supporting the occurrence of 'cures'.
Breast cancer research and treatment 1999;53(3):209-15.
1998: Valeria Bonfante; Simonetta Viviani; Armando Santoro; liliana devizzi; Anna Di Russo; M Zanini; F Soncini; H Soto Parra; Pinuccia Valagussa; Gianni Bonadonna
Ifosfamide and vinorelbine: an active regimen for patients with relapsed or refractory Hodgkin's disease.
British journal of haematology 1998;103(2):533-5.
1998: Romano Demicheli; Monica Terenziani; Gianni Bonadonna
Estimate of tumor growth time for breast cancer local recurrences: rapid growth after wake-up?
Breast cancer research and treatment 1998;51(2):133-7.
1998: Gianni Bonadonna
A new philosophy in breast cancer therapy.
The cancer journal from Scientific American 1998;4(4):224-5.
1998: Simonetta Viviani; E Camerini; Valeria Bonfante; Armando Santoro; Monica Balzarotti; Monica Fornier; liliana devizzi; P Verderio; Pinuccia Valagussa; Gianni Bonadonna
Soluble interleukin-2 receptors (sIL-2R) in Hodgkin's disease: outcome and clinical implications.
British journal of cancer 1998;77(6):992-7.
1998: Luca Gianni; Giuseppe Capri; Pinuccia Valagussa; Gianni Bonadonna
Putting taxanes to work in operable breast cancer: a search for selective indications from empirical studies.
Recent results in cancer research. Fortschritte der Krebsforschung. Progrès dans les recherches sur le cancer 1998;152():314-22.
1998: Gianni Bonadonna; Pinuccia Valagussa; C Brambilla; L Ferrari; Angela Moliterni; Monica Terenziani; Milvia Zambetti
Primary chemotherapy in operable breast cancer: eight-year experience at the Milan Cancer Institute.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(1):93-100.
1997: Romano Demicheli; Michael Retsky; Douglas Swartzendruber; Gianni Bonadonna
Proposal for a new model of breast cancer metastatic development.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1997;8(11):1075-80.
1997: Angela Moliterni; E Tarenzi; Giuseppe Capri; Monica Terenziani; A Bertuzzi; Giacomo Grasselli; Roberto Agresti; P Piotti; Marco Greco; Bruno Salvadori; Silvana Pilotti; F Lombardi; Pinuccia Valagussa; Gianni Bonadonna; Luca Gianni
Pilot study of primary chemotherapy with doxorubicin plus paclitaxel in women with locally advanced or operable breast cancer.
Seminars in oncology 1997;24(5 Suppl 17):S17-10-S17-14.
1997: Michael Retsky; Romano Demicheli; Douglas Swartzendruber; P D Bame; R H Wardwell; Gianni Bonadonna; J F Speer; Pinuccia Valagussa
Computer simulation of a breast cancer metastasis model.
Breast cancer research and treatment 1997;45(2):193-202.
1997: Milvia Zambetti; Romano Demicheli; D De Candis; G Antonelli; A Giacobone; Monica Terenziani; A Laffranchi; F Garbagnati; S Biasi; Gianni Bonadonna
Five-day infusion fluorouracil plus vinorelbine i.v. in metastatic pretreated breast cancer patients.
Breast cancer research and treatment 1997;44(3):255-60.
1997: ALESSANDRO MASSIMO GIANNI; Salvatore Siena; Marco Bregni; M Di Nicola; S Orefice; F Cusumano; Bruno Salvadori; Alberto Luini; Marco Greco; Roberto Zucali; F Rilke; Milvia Zambetti; Pinuccia Valagussa; Gianni Bonadonna
Efficacy, toxicity, and applicability of high-dose sequential chemotherapy as adjuvant treatment in operable breast cancer with 10 or more involved axillary nodes: five-year results.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1997;15(6):2312-21.
1997: C Tondini; Monica Balzarotti; Armando Santoro; M Zanini; Monica Fornier; Roberto Giardini; G Di Felice; F Bozzetti; Gianni Bonadonna
Initial chemotherapy for primary resectable large-cell lymphoma of the stomach.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1997;8(5):497-9.
1997: Luca Gianni; Lucia Viganò; Alberta Locatelli; Giuseppe Capri; A Giani; E Tarenzi; Gianni Bonadonna
Human pharmacokinetic characterization and in vitro study of the interaction between doxorubicin and paclitaxel in patients with breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1997;15(5):1906-15.
1997: ALESSANDRO MASSIMO GIANNI; Marco Bregni; Salvatore Siena; C Brambilla; Massimo Di Nicola; F Lombardi; Lorenza Gandola; Corrado Tarella; Alessandro Pileri; Fernando Ravagnani; Pinuccia Valagussa; Gianni Bonadonna
High-dose chemotherapy and autologous bone marrow transplantation compared with MACOP-B in aggressive B-cell lymphoma.
The New England journal of medicine 1997;336(18):1290-7.
1997: Valeria Bonfante; Armando Santoro; Simonetta Viviani; liliana devizzi; Monica Balzarotti; F Soncini; M Zanini; Pinuccia Valagussa; Gianni Bonadonna
Outcome of patients with Hodgkin's disease failing after primary MOPP-ABVD.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1997;15(2):528-34.
1997: liliana devizzi; Lorenzo Maffioli; Valeria Bonfante; Simonetta Viviani; L Balzarini; Massimo Gasparini; Pinuccia Valagussa; Emilio Bombardieri; Armando Santoro; Gianni Bonadonna
Comparison of gallium scan, computed tomography, and magnetic resonance in patients with mediastinal Hodgkin's disease.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1997;8 Suppl 1():53-6.
1996: Monica Balzarotti; Armando Santoro; C Tondini; Monica Fornier; Gianni Bonadonna
Activity of single agent vinorelbine in pretreated non-Hodgkin's lymphoma.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1996;7(9):970-2.
1996: liliana devizzi; Armando Santoro; Valeria Bonfante; Simonetta Viviani; Gianni Bonadonna
Vinorelbine: a new promising drug in Hodgkin's disease.
Leukemia & lymphoma 1996;22(5-6):409-14.
1996: Gianni Bonadonna; Pinuccia Valagussa
Primary chemotherapy in operable breast cancer.
Seminars in oncology 1996;23(4):464-74.
1996: Milvia Zambetti; Pinuccia Valagussa; Gianni Bonadonna
Adjuvant cyclophosphamide, methotrexate and fluorouracil in node-negative and estrogen receptor-negative breast cancer. Updated results.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1996;7(5):481-5.
1996: Simonetta Viviani; Gianni Bonadonna; Armando Santoro; Valeria Bonfante; M Zanini; liliana devizzi; F Soncini; Pinuccia Valagussa
Alternating versus hybrid MOPP and ABVD combinations in advanced Hodgkin's disease: ten-year results.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1996;14(5):1421-30.
1996: Gianni Bonadonna
Current and future trends in the multidisciplinary approach for high-risk breast cancer. The experience of the Milan Cancer Institute.
European journal of cancer (Oxford, England : 1990) 1996;32A(2):209-14.
1996: Marco Bregni; Salvatore Siena; Massimo Di Nicola; A Dodero; Fedro Alessandro Peccatori; Fernando Ravagnani; G Danesini; A Laffranchi; Gianni Bonadonna; ALESSANDRO MASSIMO GIANNI
Comparative effects of granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor after high-dose cyclophosphamide cancer therapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1996;14(2):628-35.
1996: Milvia Zambetti; Monica Terenziani; Cesare Bartoli; Pinuccia Valagussa; P Piotti; C Ferranti; Gianni Bonadonna
Intermediate doses of cyclophosphamide alone or following adriamycin in advanced breast cancer. A pilot study.
American journal of clinical oncology 1996;19(1):82-6.
1996: Romano Demicheli; A Abbattista; Rosalba Miceli; Pinuccia Valagussa; Gianni Bonadonna
Time distribution of the recurrence risk for breast cancer patients undergoing mastectomy: further support about the concept of tumor dormancy.
Breast cancer research and treatment 1996;41(2):177-85.
1996: Monica Terenziani; Romano Demicheli; C Brambilla; Leonardo Ferrari; Angela Moliterni; Milvia Zambetti; A Caraceni; C Martini; Gianni Bonadonna
Vinorelbine: an active, non cross-resistant drug in advanced breast cancer. Results from a phase II study.
Breast cancer research and treatment 1996;39(3):285-91.
1996: Pinuccia Valagussa; D De Candis; G Antonelli; Gianni Bonadonna
VIII. Women's health perception and breast cancer: issues of fertility, hormone substitution, and cancer prevention.
Recent results in cancer research. Fortschritte der Krebsforschung. Progrès dans les recherches sur le cancer 1996;140():277-83.
1996: Gianni Bonadonna
Future developments in adjuvant systemic therapy for high-risk breast cancer.
Recent results in cancer research. Fortschritte der Krebsforschung. Progrès dans les recherches sur le cancer 1996;140():227-34.
1996: Armando Santoro; Gianni Bonadonna
Soft tissue and bone sarcomas.
Cancer chemotherapy and biological response modifiers 1996;16():617-24.
1995: Gianni Bonadonna; Pinuccia Valagussa; Angela Moliterni; Milvia Zambetti; C Brambilla
Adjuvant cyclophosphamide, methotrexate, and fluorouracil in node-positive breast cancer: the results of 20 years of follow-up.
The New England journal of medicine 1995;332(14):901-6.
1995: Armando Santoro; H S Parra; P Bidoli; M Angelidou; I Cataldo; P Salvini; Pinuccia Valagussa; F Milani; Gianni Ravasi; Gianni Bonadonna
A summary of the Milan experience with multimodality therapies in patients with small cell lung cancer: attempts to improve long-term outcome.
Seminars in oncology 1995;22(1 Suppl 2):9-14.
1995: Luca Gianni; C M Kearns; A Giani; Giuseppe Capri; L Viganó; A Lacatelli; Gianni Bonadonna; Merrill J Egorin
Nonlinear pharmacokinetics and metabolism of paclitaxel and its pharmacokinetic/pharmacodynamic relationships in humans.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1995;13(1):180-90.
1994: Salvatore Siena; Marco Bregni; Massimo Di Nicola; F Ravagani; Fedro Alessandro Peccatori; L Gandola; F Lombardi; Corrado Tarella; Gianni Bonadonna; ALESSANDRO MASSIMO GIANNI
Durability of hematopoiesis following autografting with peripheral blood hematopoietic progenitors.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1994;5(10):935-41.
1994: Massimo Di Nicola; Salvatore Siena; Marco Bregni; Fernando Ravagnani; F Vitello; N Belli; A Dodero; Michele Magni; Gianni Bonadonna; ALESSANDRO MASSIMO GIANNI
Large-scale enrichment of mobilized CD34+ peripheral blood hematopoietic progenitors by removal of nylon wool-adherent mature cells.
Bone marrow transplantation 1994;14(6):863-9.
1994: Pinuccia Valagussa; Angela Moliterni; Monica Terenziani; Milvia Zambetti; Gianni Bonadonna
Second malignancies following CMF-based adjuvant chemotherapy in resectable breast cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1994;5(9):803-8.
1994: liliana devizzi; Armando Santoro; Valeria Bonfante; Simonetta Viviani; L Balzarini; Pinuccia Valagussa; Gianni Bonadonna
Vinorelbine: an active drug for the management of patients with heavily pretreated Hodgkin's disease.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1994;5(9):817-20.
1994: Pinuccia Valagussa; Milvia Zambetti; S Biasi; Angela Moliterni; Roberto Zucali; Gianni Bonadonna
Cardiac effects following adjuvant chemotherapy and breast irradiation in operable breast cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1994;5(3):209-16.
1994: ALESSANDRO MASSIMO GIANNI; Corrado Tarella; Marco Bregni; Salvatore Siena; F Lombardi; L Gandola; Daniele Caracciolo; A Stern; Gianni Bonadonna; Mario Boccadoro
High-dose sequential chemoradiotherapy, a widely applicable regimen, confers survival benefit to patients with high-risk multiple myeloma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1994;12(3):503-9.
1994: Romano Demicheli; Monica Terenziani; Pinuccia Valagussa; Angela Moliterni; Milvia Zambetti; Gianni Bonadonna
Local recurrences following mastectomy: support for the concept of tumor dormancy.
Journal of the National Cancer Institute 1994;86(1):45-8.
1994: Gianni Bonadonna
Modern treatment of malignant lymphomas: a multidisciplinary approach? The Kaplan Memorial Lecture.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1994;5 Suppl 2():5-16.
1994: Armando Santoro; Gianni Bonadonna
Soft tissue and bone sarcomas.
Cancer chemotherapy and biological response modifiers 1994;15():620-7.
1994: M Bregni; S Siena; Gianni Bonadonna; ALESSANDRO MASSIMO GIANNI
Clinical utilisation of human haematopoietic progenitors elicited in peripheral blood by recombinant human granulocyte colony-stimulating factor (rHuG-CSF).
European journal of cancer (Oxford, England : 1990) 1994;30A(2):235-8.
1993: Massimo Di Nicola; Salvatore Siena; Marco Bregni; Fedro Alessandro Peccatori; Michele Magni; Fernando Ravagnani; L Zorzino; Gianni Bonadonna; ALESSANDRO MASSIMO GIANNI
Quantization of CD34+ peripheral blood hematopoietic progenitors for autografting in cancer patients.
The International journal of artificial organs 1993;16 Suppl 5():80-2.
1993: ALESSANDRO MASSIMO GIANNI; Salvatore Siena; Marco Bregni; F Lombardi; L Gandola; Massimo Di Nicola; Michele Magni; Fedro Alessandro Peccatori; P Valagussa; Gianni Bonadonna
High-dose sequential chemo-radiotherapy with peripheral blood progenitor cell support for relapsed or refractory Hodgkin's disease--a 6-year update.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1993;4(10):889-91.
1993: ALESSANDRO MASSIMO GIANNI; Salvatore Siena; Marco Bregni; Massimo Di Nicola; Fedro Alessandro Peccatori; Michele Magni; Fernando Ravagnani; I Sklenar; Gianni Bonadonna
Recombinant human interleukin-3 hastens trilineage hematopoietic recovery following high-dose (7 g/m2) cyclophosphamide cancer therapy.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1993;4(9):759-66.
1993: Salvatore Siena; Marco Bregni; Laura Bonsi; I Sklenar; Gian Paolo Bagnara; Gianni Bonadonna; ALESSANDRO MASSIMO GIANNI
Increase in peripheral blood megakaryocyte progenitors following cancer therapy with high-dose cyclophosphamide and hematopoietic growth factors.
Experimental hematology 1993;21(12):1583-90.
1993: R Zucali; P Bidoli; P M Salvini; Armando Santoro; S Spinazzè; Gianni Bonadonna; M Valente; M Alloisio; Gianni Ravasi
Combined radiation and chemotherapy in esophageal cancer.
Rays 1993;18(3):382-7.
1993: Gianni Bonadonna; Luca Gianni; Armando Santoro; Valeria Bonfante; P Bidoli; P Casali; R Demicheli; Pinuccia Valagussa
Drugs ten years later: epirubicin.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1993;4(5):359-69.
1993: C Tondini; M Zanini; F Lombardi; C Bengala; Andrea Rocca; Roberto Giardini; R Buzzoni; Pinuccia Valagussa; Gianni Bonadonna
Combined modality treatment with primary CHOP chemotherapy followed by locoregional irradiation in stage I or II histologically aggressive non-Hodgkin's lymphomas.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1993;11(4):720-5.
1993: Pinuccia Valagussa; Angela Moliterni; Milvia Zambetti; Gianni Bonadonna
Long-term sequelae from adjuvant chemotherapy.
Recent results in cancer research. Fortschritte der Krebsforschung. Progrès dans les recherches sur le cancer 1993;127():247-55.
1993: Gianni Bonadonna
What did we learn from the results of the international overview about the effects of endocrine therapy?
Recent results in cancer research. Fortschritte der Krebsforschung. Progrès dans les recherches sur le cancer 1993;127():159-61.
1993: Gianni Bonadonna; U Veronesi; C Brambilla; L Ferrari; P Passoni; G F Coopmans de Yoldi; A Luini; Marco Greco; Pinuccia Valagussa
Primary chemotherapy for resectable breast cancer.
Recent results in cancer research. Fortschritte der Krebsforschung. Progrès dans les recherches sur le cancer 1993;127():113-7.
1993: Armando Santoro; Gianni Bonadonna
Soft tissue and bone sarcomas.
Cancer chemotherapy and biological response modifiers 1993;14():594-605.
1992: ALESSANDRO MASSIMO GIANNI; Marco Bregni; Salvatore Siena; Michele Magni; Massimo Di Nicola; F Lombardi; Corrado Tarella; A Pileri; Gianni Bonadonna
Granulocyte-macrophage colony-stimulating factor or granulocyte colony-stimulating factor infusion makes high-dose etoposide a safe outpatient regimen that is effective in lymphoma and myeloma patients.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1992;10(12):1955-62.
1992: ALESSANDRO MASSIMO GIANNI; S Siena; M Bregni; Gianni Bonadonna
The use of GM-CSF and peripheral blood stem cells (PBSC) minimises haematological toxicity following a myeloablative course of chemo-radiotherapy.
Pathologie-biologie 1992;39(9):956.
1992: Marco Bregni; Michele Magni; Salvatore Siena; Massimo Di Nicola; Gianni Bonadonna; ALESSANDRO MASSIMO GIANNI
Human peripheral blood hematopoietic progenitors are optimal targets of retroviral-mediated gene transfer.
Blood 1992;80(6):1418-22.
1992: Pinuccia Valagussa; Armando Santoro; Gianni Bonadonna
Thyroid, pulmonary, and cardiac sequelae after treatment for Hodgkin's disease.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1992;3 Suppl 4():111-5.
1992: C Ferranti; S Bergonzi; G Viganotti; G Piragine; M Barberini; Gianni Bonadonna; G Coopmans De Yoldi
[Microcalcifications in the diagnosis and follow-up after the primary chemotherapy of breast neoplasms].
La Radiologia medica 1992;84(1-2):26-31.
1992: Gianni Bonadonna
Evolving concepts in the systemic adjuvant treatment of breast cancer.
Cancer research 1992;52(8):2127-37.
1992: P Casali; U Pastorino; P Zucchinelli; liliana devizzi; A Azzarelli; V Quagliuolo; P Bignami; Armando Santoro; Gianni Bonadonna
Epirubicin plus ifosfamide and dacarbazine (EID) in advanced soft tissue sarcomas.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1992;3 Suppl 2():S125-6.
1992: Valeria Bonfante; Armando Santoro; Simonetta Viviani; Pinuccia Valagussa; Gianni Bonadonna
ABVD in the treatment of Hodgkin's disease.
Seminars in oncology 1992;19(2 Suppl 5):38-44; discussion 44-5.
1992: Valeria Bonfante; Armando Santoro; Simonetta Viviani; Roberto Zucali; liliana devizzi; M Zanini; J D Tesoro Tess; Pinuccia Valagussa; A Banfi; Gianni Bonadonna
Early stage Hodgkin's disease: ten-year results of a non-randomised study with radiotherapy alone or combined with MOPP.
European journal of cancer (Oxford, England : 1990) 1992;29A(1):24-9.
1991: R Buzzoni; Gianni Bonadonna; Pinuccia Valagussa; Milvia Zambetti
Adjuvant chemotherapy with doxorubicin plus cyclophosphamide, methotrexate, and fluorouracil in the treatment of resectable breast cancer with more than three positive axillary nodes.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1991;9(12):2134-40.
1991: Gianni Bonadonna; Pinuccia Valagussa; C Brambilla; Angela Moliterni; Milvia Zambetti; Leonardo Ferrari
Adjuvant and neoadjuvant treatment of breast cancer with chemotherapy and/or endocrine therapy.
Seminars in oncology 1991;18(6):515-24.
1991: Luca Gianni; Giuseppe Capri; Marco Greco; Fabrizio Villani; C Brambilla; A Luini; F Crippa; Gianni Bonadonna
Activity and toxicity of 4'-iodo-4'-deoxydoxorubicin in patients with advanced breast cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1991;2(10):719-25.
1991: ALESSANDRO MASSIMO GIANNI; Salvatore Siena; Marco Bregni; F Lombardi; L Gandola; Pinuccia Valagussa; Gianni Bonadonna
Prolonged disease-free survival after high-dose sequential chemo-radiotherapy and haemopoietic autologous transplantation in poor prognosis Hodgkin's disease.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1991;2(9):645-53.
1991: Angela Moliterni; Gianni Bonadonna; Pinuccia Valagussa; Leonardo Ferrari; Milvia Zambetti
Cyclophosphamide, methotrexate, and fluorouracil with and without doxorubicin in the adjuvant treatment of resectable breast cancer with one to three positive axillary nodes.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1991;9(7):1124-30.
1991: Salvatore Siena; Marco Bregni; B Brando; N Belli; P M Lansdorp; Gianni Bonadonna; ALESSANDRO MASSIMO GIANNI
Flow cytometry to estimate circulating hematopoietic progenitors for autologous transplantation: comparative analysis of different CD34 monoclonal antibodies.
Haematologica 1991;76(4):330-3.
1991: C Brambilla; A Escobedo; R Artioli; M J Lechuga; M Motta; Gianni Bonadonna
Medical castration with zoladex: a conservative approach to premenopausal breast cancer.
Tumori 1991;77(2):145-50.
1991: Simonetta Viviani; Gianni Bonadonna; Armando Santoro; M Zanini; Roberto Zucali; E Negretti; Pinuccia Valagussa
Alternating versus hybrid MOPP-ABVD in Hodgkin's disease: the Milan experience.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1991;2 Suppl 2():55-62.
1991: Salvatore Siena; Marco Bregni; B Brando; N Belli; Fernando Ravagnani; L Gandola; A C Stern; P M Lansdorp; Gianni Bonadonna; ALESSANDRO MASSIMO GIANNI
Flow cytometry for clinical estimation of circulating hematopoietic progenitors for autologous transplantation in cancer patients.
Blood 1991;77(2):400-9.
1991: Simonetta Viviani; Guido Ragni; Armando Santoro; L Perotti; E Caccamo; E Negretti; Pinuccia Valagussa; Gianni Bonadonna
Testicular dysfunction in Hodgkin's disease before and after treatment.
European journal of cancer (Oxford, England : 1990) 1991;27(11):1389-92.
1991: Marco Bregni; Salvatore Siena; Michele Magni; Gianni Bonadonna; ALESSANDRO MASSIMO GIANNI
Circulating hemopoietic progenitors mobilized by cancer chemotherapy and by rhGM-CSF in the treatment of high-grade non-Hodgkin's lymphoma.
Leukemia 1991;5 Suppl 1():123-7.
1991: Gianni Bonadonna; Armando Santoro; ALESSANDRO MASSIMO GIANNI; Simonetta Viviani; Salvatore Siena; Marco Bregni; Roberto Zucali; F Lombardi; Valeria Bonfante; Luca Gianni
Primary and salvage chemotherapy in advanced Hodgkin's disease: the Milan Cancer Institute experience.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1991;2 Suppl 1():9-16.
1990: Gianni Bonadonna; U Veronesi; C Brambilla; Leonardo Ferrari; A Luini; Marco Greco; C Bartoli; G Coopmans de Yoldi; Roberto Zucali; F Rilke
Primary chemotherapy to avoid mastectomy in tumors with diameters of three centimeters or more.
Journal of the National Cancer Institute 1990;82(19):1539-45.
1990: R Silvestrini; Maria Grazia Daidone; Pinuccia Valagussa; G Di Fronzo; G Mezzanotte; Luigi Mariani; Gianni Bonadonna
3H-thymidine-labeling index as a prognostic indicator in node-positive breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1990;8(8):1321-6.
1990: ALESSANDRO MASSIMO GIANNI; Corrado Tarella; Salvatore Siena; Marco Bregni; Mario Boccadoro; F Lombardi; C Bengala; Gianni Bonadonna; A Pileri
Durable and complete hematopoietic reconstitution after autografting of rhGM-CSF exposed peripheral blood progenitor cells.
Bone marrow transplantation 1990;6(2):143-5.
1990: Gianni Bonadonna; Pinuccia Valagussa
Influence of clinical trials on current treatment strategy for Hodgkin's disease.
International journal of radiation oncology, biology, physics 1990;19(1):209-18.
1990: Milvia Zambetti; Luca Gianni; F Di Re; G Spatti; Rosanna Fontanelli; A Escobedo; Giuseppe De Palo; Gianni Bonadonna
Cisplatin and cyclophosphamide in advanced ovarian carcinoma: activity and toxicity of an ambulatory regimen.
American journal of clinical oncology 1990;13(3):199-203.
1990: Pinuccia Valagussa; Milvia Zambetti; Gianni Bonadonna; Roberto Zucali; G Mezzanotte; U Veronesi
Prognostic factors in locally advanced noninflammatory breast cancer. Long-term results following primary chemotherapy.
Breast cancer research and treatment 1990;15(3):137-47.
1990: ALESSANDRO MASSIMO GIANNI; Marco Bregni; Salvatore Siena; A Orazi; A C Stern; L Gandola; Gianni Bonadonna
Recombinant human granulocyte-macrophage colony-stimulating factor reduces hematologic toxicity and widens clinical applicability of high-dose cyclophosphamide treatment in breast cancer and non-Hodgkin's lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1990;8(5):768-78.
1990: Luca Gianni; Lucia Viganò; A Surbone; D Ballinari; P Casali; C Tarella; J M Collins; Gianni Bonadonna
Pharmacology and clinical toxicity of 4'-iodo-4'-deoxydoxorubicin: an example of successful application of pharmacokinetics to dose escalation in phase I trials.
Journal of the National Cancer Institute 1990;82(6):469-77.
1990: Gianni Bonadonna; A Santoro
Current issues in the management of advanced Hodgkin's disease.
Blood reviews 1990;4(1):69-73.
1990: Marco Bregni; Salvatore Siena; Fernando Ravagnani; Gianni Bonadonna; ALESSANDRO MASSIMO GIANNI
High-dose cyclophosphamide in patients with operable breast cancer: recombinant human GM-CSF ameliorates drug-induced leukopenia and thrombocytopenia.
Haematologica 1990;75 Suppl 1():95-8.
1990: Salvatore Siena; Marco Bregni; Fernando Ravagnani; B Brando; Corrado Tarella; Gianni Bonadonna; ALESSANDRO MASSIMO GIANNI
Heterogeneity of circulating hematopoietic progenitors in cancer patients treated with high-dose cyclophosphamide and recombinant human granulocyte macrophage colony stimulating factor (rhGM-CSF).
Haematologica 1990;75 Suppl 1():6-10.
1990: Gianni Bonadonna
Adjuvant chemotherapy in node-negative breast cancer. NCI consensus conference.
European journal of cancer (Oxford, England : 1990) 1990;26(7):844-5.
1990: Gianni Bonadonna
Does chemotherapy fulfill its expectations in cancer treatment?
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1990;1(1):11-21.
1990: Simonetta Viviani; Armando Santoro; E Negretti; Valeria Bonfante; Pinuccia Valagussa; Gianni Bonadonna
Salvage chemotherapy in Hodgkin's disease. Results in patients relapsing more than twelve months after first complete remission.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1990;1(2):123-7.
1989: Salvatore Siena; Marco Bregni; B Brando; Fernando Ravagnani; Gianni Bonadonna; ALESSANDRO MASSIMO GIANNI
Circulation of CD34+ hematopoietic stem cells in the peripheral blood of high-dose cyclophosphamide-treated patients: enhancement by intravenous recombinant human granulocyte-macrophage colony-stimulating factor.
Blood 1989;74(6):1905-14.
1989: Gianni Bonadonna
Karnofsky memorial lecture. Conceptual and practical advances in the management of breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1989;7(10):1380-97.
1989: ALESSANDRO MASSIMO GIANNI; Salvatore Siena; Marco Bregni; C Tarella; A C Stern; A Pileri; Gianni Bonadonna
Granulocyte-macrophage colony-stimulating factor to harvest circulating haemopoietic stem cells for autotransplantation.
Lancet 1989;2(8663):580-5.
1989: R Silvestrini; Maria Grazia Daidone; Pinuccia Valagussa; G Di Fronzo; G Mezzanotte; Gianni Bonadonna
Cell kinetics as a prognostic indicator in node-negative breast cancer.
European journal of cancer & clinical oncology 1989;25(8):1165-71.
1989: ALESSANDRO MASSIMO GIANNI; Gianni Bonadonna
High dose chemo-radiotherapy for sensitive tumors: is sequential better than concurrent drug delivery?
European journal of cancer & clinical oncology 1989;25(7):1027-30.
1989: Salvatore Siena; Marco Bregni; A Formosa; B Brando; P Marenco; D A Lappi; Gianni Bonadonna; ALESSANDRO MASSIMO GIANNI
Immunotoxin-mediated inhibition of chronic lymphocytic leukemia cell proliferation in humans.
Cancer research 1989;49(12):3328-32.
1989: C Brambilla; Milvia Zambetti; Leonardo Ferrari; Gianni Bonadonna
Mitomycin C and vinblastine in advanced refractory breast cancer.
Tumori 1989;75(2):141-4.
1989: Milvia Zambetti; Luca Gianni; A Escobedo; Paolo Pizzetti; G B Spatti; Gianni Bonadonna
First-line chemotherapy with intraperitoneal cisplatin and intravenous cyclophosphamide in ovarian carcinoma. A preliminary report.
American journal of clinical oncology 1989;12(2):118-22.
1989: Salvatore Siena; Marco Bregni; A Formosa; B Brando; D A Lappi; Gianni Bonadonna; ALESSANDRO MASSIMO GIANNI
Immunotoxin mediated killing of clonable T-lymphocytes infiltrating an irreversibly rejected human renal allograft.
Journal of biological regulators and homeostatic agents 1989;3(2):84-8.
1989: Marco Bregni; Salvatore Siena; A Neri; R Bassan; T Barbui; D Delia; Gianni Bonadonna; R Dalla Favera; ALESSANDRO MASSIMO GIANNI
Minimal residual disease in acute lymphoblastic leukemia detected by immune selection and gene rearrangement analysis.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1989;7(3):338-43.
1989: ALESSANDRO MASSIMO GIANNI; Marco Bregni; Salvatore Siena; S Villa; Gianalfredo Sciorelli; Fernando Ravagnani; G Pellegris; Gianni Bonadonna
Rapid and complete hemopoietic reconstitution following combined transplantation of autologous blood and bone marrow cells. A changing role for high dose chemo-radiotherapy?
Hematological oncology 1989;7(2):139-48.
1989: P Bidoli; S Spinazzé; Armando Santoro; A V Bedini; I Cataldo; Gianni Bonadonna
Pilot study with adriamycin and ifosfamide in small cell lung cancer.
Tumori 1989;75(1):34-7.
1989: Marco Bregni; Salvatore Siena; A Formosa; D A Lappi; D Martineau; F Malavasi; B Dorken; Gianni Bonadonna; ALESSANDRO MASSIMO GIANNI
B-cell restricted saporin immunotoxins: activity against B-cell lines and chronic lymphocytic leukemia cells.
Blood 1989;73(3):753-62.
1989: Pinuccia Valagussa; C Brambilla; Milvia Zambetti; Gianni Bonadonna
Salvage treatments in relapsing resectable breast cancer.
Recent results in cancer research. Fortschritte der Krebsforschung. Progrès dans les recherches sur le cancer 1989;115():69-76.
1989: Gianni Bonadonna; Pinuccia Valagussa; Milvia Zambetti; C Brambilla
The Milan experience with adjuvant chemotherapy in premenopausal breast cancer.
Recent results in cancer research. Fortschritte der Krebsforschung. Progrès dans les recherches sur le cancer 1989;115():113-7.
1989: Gianni Bonadonna; Milvia Zambetti; Pinuccia Valagussa
Adjuvant chemotherapy for node-negative breast cancer patients.
Recent results in cancer research. Fortschritte der Krebsforschung. Progrès dans les recherches sur le cancer 1989;115():175-9.
1989: Gianni Bonadonna; Pinuccia Valagussa; A Santoro; Simonetta Viviani; Valeria Bonfante; A Banfi
Hodgkin's disease: the Milan Cancer Institute experience with MOPP and ABVD.
Recent results in cancer research. Fortschritte der Krebsforschung. Progrès dans les recherches sur le cancer 1989;117():169-74.
1988: Salvatore Siena; Marco Bregni; A Formosa; D Martineau; D A Lappi; Gianni Bonadonna; ALESSANDRO MASSIMO GIANNI
Evaluation of antihuman T lymphocyte saporin immunotoxins potentially useful in human transplantation.
Transplantation 1988;46(5):747-53.
1988: C Verusio; Emilio Bajetta; L Ferrari; C Bartoli; Pinuccia Valagussa; Gianni Bonadonna
Cyclophosphamide, adriamycin, and cis-platinum (CAP) in metastatic and locally advanced breast cancer.
American journal of clinical oncology 1988;11(4):435-9.
1988: Salvatore Siena; D A Lappi; Marco Bregni; A Formosa; S Villa; Marco Soria; Gianni Bonadonna; ALESSANDRO MASSIMO GIANNI
Synthesis and characterization of an antihuman T-lymphocyte saporin immunotoxin (OKT1-SAP) with in vivo stability into nonhuman primates.
Blood 1988;72(2):756-65.
1988: Emilio Bajetta; Pinuccia Valagussa; Gianni Bonadonna; A Lattuada; R Buzzoni; F Rilke; A Banfi
Combined modality treatment for stage I-II non-Hodgkin's lymphomas: CVP versus BACOP chemotherapy.
International journal of radiation oncology, biology, physics 1988;15(1):3-12.
1988: Marco Bregni; D A Lappi; Salvatore Siena; A Formosa; S Villa; Marco Soria; Gianni Bonadonna; ALESSANDRO MASSIMO GIANNI
Activity of a monoclonal antibody-saporin-6 conjugate against B-lymphoma cells.
Journal of the National Cancer Institute 1988;80(7):511-7.
1988: Gianni Bonadonna; P Valagussa
The contribution of medicine to the primary treatment of breast cancer.
Cancer research 1988;48(9):2314-24.
1988: Emilio Bajetta; R Buzzoni; Pinuccia Valagussa; Gianni Bonadonna
Mitoxantrone: an active agent in refractory non-Hodgkin's lymphomas.
American journal of clinical oncology 1988;11(2):100-3.
1987: Leonardo Ferrari; Emilio Bajetta; Luca Gianni; C Verusio; C Bartoli; Pinuccia Valagussa; Gianni Bonadonna
Four-drug sequential regimen in advanced breast cancer.
Breast cancer research and treatment 1987;10(2):151-7.
1987: R B Weiss; Pinuccia Valagussa; Angela Moliterni; Milvia Zambetti; R Buzzoni; Gianni Bonadonna
Adjuvant chemotherapy after conservative surgery plus irradiation versus modified radical mastectomy. Analysis of drug dosing and toxicity.
The American journal of medicine 1987;83(3):455-63.
1987: M Zambetti; C Brambilla; G Tancini; Gianni Bonadonna
Aminoglutethimide in postmenopausal breast cancer refractory to multiple hormonal and cytostatic treatments.
Tumori 1987;73(4):369-73.
1987: Salvatore Siena; S Villa; Gianni Bonadonna; Marco Bregni; ALESSANDRO MASSIMO GIANNI
Ex vivo depletion of human bone marrow T lymphocytes by soybean lectin fractionation followed by treatment with an anti-pan-T cell (CD5) ricin A- chain immunotoxin.
Transplantation proceedings 1987;19(1 Pt 3):2735-7.
1986: Pinuccia Valagussa; A Santoro; F Fossati-Bellani; A Banfi; Gianni Bonadonna
Second acute leukemia and other malignancies following treatment for Hodgkin's disease.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1986;4(6):830-7.
1984: Gianni Bonadonna; P Bignami; R Buzzoni; Angela Moliterni; Pinuccia Valagussa; U Veronesi
New adjuvant trials for resectable breast cancer at the Istituto Nazionale Tumori of Milan.
Recent results in cancer research. Fortschritte der Krebsforschung. Progrès dans les recherches sur le cancer 1984;91():210-3.
1983: Emilio Bajetta; R Buzzoni; F Rilke; P Valagussa; R Rovej; Simonetta Viviani; A Lattuada; A Banfi; Gianni Bonadonna
Non-Hodgkin's lymphomas of Waldeyer's ring.
Tumori 1983;69(2):129-36.
1982: Pinuccia Valagussa; A Santoro; F Fossati Bellani; F Franchi; A Banfi; Gianni Bonadonna
Absence of treatment-induced second neoplasms after ABVD in Hodgkin's disease.
Blood 1982;59(3):488-94.
1981: Gianni Bonadonna; A Rossi; G Tancini; E Bajetta; S Marchini; C Brambilla; J D Tesoro Tess; Pinuccia Valagussa; A Banfi; U Veronesi
Adjuvant combination chemotherapy for operable breast cancer. Trials in progress at the Istituto Nazionale Tumori of Milan.
Cancer treatment reports 1981;65 Suppl 1():61-5.
1980: S Monfardini; A Banfi; Gianni Bonadonna; F Rilke; F Milani; Pinuccia Valagussa; A Lattuada
Improved five year survival after combined radiotherapy-chemotherapy for stage I-II non-Hodgkin's lymphoma.
International journal of radiation oncology, biology, physics 1980;6(2):125-34.
1980: Pinuccia Valagussa; A Santoro; R Kenda; F Fossati Bellani; F Franchi; A Banfi; F Rilke; Gianni Bonadonna
Second malignancies in Hodgkin's disease: a complication of certain forms of treatment.
British medical journal 1980;280(6209):216-9.